AMJ Land Holdings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 6:27 pm

Competitors of AMJ Land Holdings Ltd

All Competitor Stocks of AMJ Land Holdings Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:50 pm

Below is a detailed analysis of the quarterly data for AMJ Land Holdings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 14.27 Cr.. The value appears to be declining and may need further review. It has decreased from 25.49 Cr. (Mar 2025) to 14.27 Cr., marking a decrease of 11.22 Cr..
• For Expenses, as of Jun 2025, the value is 10.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.96 Cr. (Mar 2025) to 10.29 Cr., marking an increase of 0.33 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.98 Cr.. The value appears to be declining and may need further review. It has decreased from 15.53 Cr. (Mar 2025) to 3.98 Cr., marking a decrease of 11.55 Cr..
• For OPM %, as of Jun 2025, the value is 27.89%. The value appears to be declining and may need further review. It has decreased from 60.93% (Mar 2025) to 27.89%, marking a decrease of 33.04%.
• For Other Income, as of Jun 2025, the value is 1.93 Cr.. The value appears strong and on an upward trend. It has increased from 1.91 Cr. (Mar 2025) to 1.93 Cr., marking an increase of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.47 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.44 Cr.. The value appears to be declining and may need further review. It has decreased from 16.97 Cr. (Mar 2025) to 5.44 Cr., marking a decrease of 11.53 Cr..
• For Tax %, as of Jun 2025, the value is 33.64%. The value appears to be improving (decreasing) as expected. It has decreased from 35.30% (Mar 2025) to 33.64%, marking a decrease of 1.66%.
• For Net Profit, as of Jun 2025, the value is 3.61 Cr.. The value appears to be declining and may need further review. It has decreased from 10.98 Cr. (Mar 2025) to 3.61 Cr., marking a decrease of 7.37 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.85. The value appears to be declining and may need further review. It has decreased from 2.54 (Mar 2025) to 0.85, marking a decrease of 1.69.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:47 am

Growth

Last Updated: September 4, 2025, 11:10 pm

Balance Sheet

Last Updated: June 16, 2025, 12:30 pm

Below is a detailed analysis of the balance sheet data for AMJ Land Holdings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 219.00 Cr.. The value appears strong and on an upward trend. It has increased from 171.00 Cr. (Mar 2024) to 219.00 Cr., marking an increase of 48.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 15.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 15.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 269.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 230.00 Cr. (Mar 2024) to 269.00 Cr., marking an increase of 39.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 163.00 Cr.. The value appears strong and on an upward trend. It has increased from 118.00 Cr. (Mar 2024) to 163.00 Cr., marking an increase of 45.00 Cr..
• For Other Assets, as of Mar 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 84.00 Cr. (Mar 2024) to 80.00 Cr., marking a decrease of 4.00 Cr..
• For Total Assets, as of Mar 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 230.00 Cr. (Mar 2024) to 269.00 Cr., marking an increase of 39.00 Cr..

Notably, the Reserves (219.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for AMJ Land Holdings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 2.71 (Mar 24) to 4.99, marking an increase of 2.28.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 2.71 (Mar 24) to 4.99, marking an increase of 2.28.
• For Cash EPS (Rs.), as of Mar 25, the value is 5.55. This value is within the healthy range. It has increased from 3.16 (Mar 24) to 5.55, marking an increase of 2.39.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.40. It has increased from 43.87 (Mar 24) to 55.40, marking an increase of 11.53.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.40. It has increased from 43.87 (Mar 24) to 55.40, marking an increase of 11.53.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 18.94. It has increased from 13.77 (Mar 24) to 18.94, marking an increase of 5.17.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.42. This value is within the healthy range. It has increased from 4.30 (Mar 24) to 8.42, marking an increase of 4.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.96. This value is within the healthy range. It has increased from 3.84 (Mar 24) to 7.96, marking an increase of 4.12.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has increased from 3.41 (Mar 24) to 7.73, marking an increase of 4.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.09. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 5.09, marking an increase of 2.40.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.99. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 4.99, marking an increase of 2.28.
• For PBDIT Margin (%), as of Mar 25, the value is 44.44. This value is within the healthy range. It has increased from 31.21 (Mar 24) to 44.44, marking an increase of 13.23.
• For PBIT Margin (%), as of Mar 25, the value is 42.01. This value exceeds the healthy maximum of 20. It has increased from 27.86 (Mar 24) to 42.01, marking an increase of 14.15.
• For PBT Margin (%), as of Mar 25, the value is 40.82. This value is within the healthy range. It has increased from 24.73 (Mar 24) to 40.82, marking an increase of 16.09.
• For Net Profit Margin (%), as of Mar 25, the value is 26.86. This value exceeds the healthy maximum of 10. It has increased from 19.55 (Mar 24) to 26.86, marking an increase of 7.31.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 26.35. This value exceeds the healthy maximum of 20. It has increased from 19.65 (Mar 24) to 26.35, marking an increase of 6.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.01. This value is below the healthy minimum of 15. It has increased from 6.20 (Mar 24) to 9.01, marking an increase of 2.81.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.68. This value is within the healthy range. It has increased from 8.04 (Mar 24) to 13.68, marking an increase of 5.64.
• For Return On Assets (%), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 4.83 (Mar 24) to 7.59, marking an increase of 2.76.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.00, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.31. It has increased from 0.27 (Mar 24) to 0.31, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 4.05. This value exceeds the healthy maximum of 3. It has increased from 3.43 (Mar 24) to 4.05, marking an increase of 0.62.
• For Quick Ratio (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 2. It has increased from 2.10 (Mar 24) to 3.20, marking an increase of 1.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.16, marking an increase of 2.16.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.00. This value is below the healthy minimum of 20. It has decreased from 7.39 (Mar 24) to 4.00, marking a decrease of 3.39.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.66. This value is below the healthy minimum of 20. It has decreased from 6.31 (Mar 24) to 3.66, marking a decrease of 2.65.
• For Earning Retention Ratio (%), as of Mar 25, the value is 96.00. This value exceeds the healthy maximum of 70. It has increased from 92.61 (Mar 24) to 96.00, marking an increase of 3.39.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.34. This value exceeds the healthy maximum of 70. It has increased from 93.69 (Mar 24) to 96.34, marking an increase of 2.65.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 37.18. This value is within the healthy range. It has increased from 9.98 (Mar 24) to 37.18, marking an increase of 27.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.48. This value is within the healthy range. It has increased from 7.25 (Mar 24) to 23.48, marking an increase of 16.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 160.34. It has increased from 140.09 (Mar 24) to 160.34, marking an increase of 20.25.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 2.06, marking a decrease of 0.42.
• For EV / EBITDA (X), as of Mar 25, the value is 4.65. This value is below the healthy minimum of 5. It has decreased from 7.95 (Mar 24) to 4.65, marking a decrease of 3.30.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has decreased from 2.44 (Mar 24) to 2.42, marking a decrease of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 95.99. This value exceeds the healthy maximum of 70. It has increased from 92.60 (Mar 24) to 95.99, marking an increase of 3.39.
• For Price / BV (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 24) to 0.82, marking an increase of 0.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has decreased from 2.44 (Mar 24) to 2.42, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.10, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness